课题基金 / 基金详情

Radiochemistry

Radiochemistry
放射化学
批准号:
CRC-2015-00091
负责人:
Price, Eric
金额:
$8.74万
依托单位:
依托单位国家:
加拿大
项目类别:
Canada Research Chairs
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31
关键词:

项目摘要

项目成果

Price, Eric的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Two fields of health research that benefit greatly from radioactive pharmaceuticals (radioactive drugs) are cancer and bacterial infections. Radiopharmaceuticals can be used with very sensitive molecular imaging techniques to learn new information about important biological and physiological processes. Radiopharmaceutical agents are routinely used for early detection, staging, and treatment of cancer, and also for imaging bacterial infections. The objective of this Canada Research Chair will be the creation of new radiopharmaceuticals to selectively target a number of unique types of cancer to provide improved and personalized medicine, and to pioneer new radioactive therapeutic agents to treat the emerging threat of multi-drug resistant bacteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Radiochemistry
  • 批准号:
    CRC-2020-00110
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Price, Eric
  • 依托单位:
New Chelators and Multifunctional Linkers for Enhancing Molecular Imaging Agents: Putting Radiometals into Radiopharmaceuticals
  • 批准号:
    RGPIN-2017-03952
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.06万
  • 财政年份:
    2022
  • 负责人:
    Price, Eric
  • 依托单位:
Radiochemistry
  • 批准号:
    CRC-2015-00091
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $2.19万
  • 财政年份:
    2021
  • 负责人:
    Price, Eric
  • 依托单位:
New Chelators and Multifunctional Linkers for Enhancing Molecular Imaging Agents: Putting Radiometals into Radiopharmaceuticals
  • 批准号:
    RGPIN-2017-03952
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.53万
  • 财政年份:
    2021
  • 负责人:
    Price, Eric
  • 依托单位:
海外基金